Phosphoramidite Market Size Worth USD 2.40 Billion by 2034 | CAGR: 8.13%

The phosphoramidites market size is expected to reach USD 2.40 Billion by 2034, according to a new study by Polaris Market Research. The report “Phosphoramidite Market Share, Size, Trends, Industry Analysis Report: By Type (DNA Phosphoramidites, RNA Phosphoramidites), By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Global phosphoramidites are widely used across pharmaceutical, biotechnology, academic research and diagnostic sectors to enable oligonucleotide synthesis for therapeutics, genetic testing, and molecular biology applications. Phosphoramidite solutions include DNA, RNA, labeled, and modifier derivatives, fueled by specialized synthesis processes, automation, and value-added services tailored to end-user requirements.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/phosphoramidite-market/request-for-sample

Market growth is primarily driven by increasing investments in nucleic acid therapeutics, rising prevalence of genetic disorders, and expanding research in gene editing, synthetic biology, and personalized medicine.

Phosphoramidite Market Report Highlights

• Based on type, the DNA phosphoramidites segment dominated the market in 2024, driven by widespread use in oligonucleotide synthesis for drug discovery and diagnostics.
• In terms of application, the drug discovery and development segment led in 2024, fueled by increasing R&D in nucleic acid-based therapeutics.
• Based on end user, the pharmaceutical and biotechnology companies segment dominated in 2024, driven by high demand for nucleic acid therapeutics, diagnostics, and strategic collaborations.
• In terms of region, the North America held the dominant share in 2024, propelled by leading pharmaceutical companies, strong R&D infrastructure, and advanced biotechnology investment.
• Asia Pacific is expected to grow at the fastest CAGR, driven by government initiatives supporting biotech innovation, expanding pharmaceutical manufacturing, and increasing CRO activities.
• Key players in the global market include Thermo Fisher Scientific, Merck KGaA, Cytiva, LGC Biosearch Technologies, Integrated DNA Technologies, Synthena AG, Bioneer Corporation, GenePharma Co., Ltd., Takara Bio Inc., Wuhan Sun Biological Engineering Co., Ltd., BioAutomation, LLC, and CEM Corporation.

Polaris Market Research has segmented the market report based on type, application, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• DNA Phosphoramidites
• RNA Phosphoramidites
• Labeled Phosphoramidites
• Modifier Phosphoramidites
• Other Types

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Drug Discovery & Development
• Diagnostics Development
• Gene Editing & Synthetic Biology
• Other Applications

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Other End Users

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America